iShares Global Healthcare ETF (IXJ)
An exchange-traded fund listed on AMEX. A fund is not a company: it has no filed accounts of its own here, and it is never ranked beside companies. Every figure below is market data, with the day it was supplied.
Price
Last close 107.21 USD on Oct 15, 2026. Market data, supplied Oct 15, 2026.
What it costs
| Expense ratio | 0.38% |
| Assets under management | 4.44B USD |
| Net asset value per share | 104.99 USD |
| Inception | Nov 13, 2001 |
| Sponsor | IShares |
| Asset class | Equity |
| Holdings the fund reports | 109 |
Market data, supplied Oct 15, 2026.
What it holds
The largest 25 by weight of the 128 holdings in the snapshot of Oct 15, 2026. A fund is marked as a fund, and a holding that is not a company's share (a bond, a bill, cash, an option or a swap) is marked as not a company.
| # | Holding | Weight |
|---|---|---|
| 1 | ELI LILLY | 10.65% |
| 2 | JOHNSON & JOHNSON | 6.74% |
| 3 | ABBVIE | 5.52% |
| 4 | MERCK & CO INC | 4.40% |
| 5 | UNITEDHEALTH GROUP | 4.30% |
| 6 | ROCHE PS PAR AG | 3.76% |
| 7 | NOVARTIS AG | 3.24% |
| 8 | ASTRAZENECA PLC | 3.04% |
| 9 | THERMO FISHER SCIENTIFIC | 3.01% |
| 10 | AMGEN INC | 2.79% |
| 11 | GILEAD SCIENCES | 2.31% |
| 12 | ABBOTT LABORATORIES | 2.16% |
| 13 | PFIZER | 2.02% |
| 14 | INTUITIVE SURGICAL | 1.80% |
| 15 | DANAHER | 1.70% |
| 16 | VERTEX PHARMACEUTICALS | 1.53% |
| 17 | NOVO NORDISK CLASS B | 1.47% |
| 18 | BRISTOL MYERS SQUIBB | 1.47% |
| 19 | CVS HEALTH | 1.40% |
| 20 | MEDTRONIC PLC | 1.40% |
| 21 | MCKESSON CORP | 1.38% |
| 22 | STRYKER | 1.19% |
| 23 | GLAXOSMITHKLINE | 1.17% |
| 24 | ELEVANCE HEALTH INC | 1.12% |
| 25 | SANOFI SA | 1.04% |
Market data, supplied Oct 15, 2026.
Sector weights
| Pharma, Biotech & Life Sciences | 70.31% |
| Health Care Equipment & Services | 29.32% |
| Cash and/or Derivatives | 0.37% |
Market data, supplied Oct 15, 2026.
Country weights
| United States | 72.72% |
| Switzerland | 9.78% |
| United Kingdom | 4.89% |
| Japan | 3.53% |
| Denmark | 1.88% |
| France | 1.71% |
| Germany | 1.47% |
| Ireland | 1.40% |
| Australia | 1.03% |
| Netherlands | 0.98% |
| Belgium | 0.33% |
| Brazil | 0.11% |
| Luxembourg | 0.11% |
| Sweden | 0.07% |
| Other | 0.01% |
Market data, supplied Oct 15, 2026.
Look-through value
Earnings yield, P/E and book yield of the holdings taken together: n/a. Look-through figures are not measured for this fund yet.